Literature DB >> 30520936

Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual.

Daniel Shepshelovich1,2, Ariadna Tibau3, Consolación Molto3, Hadar Goldvaser1,4, Alberto Ocana5,6, Bostjan Šeruga7, Eitan Amir1,8.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30520936      PMCID： PMC6440244          DOI： 10.1001/jamaoncol.2018.5877

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

Review 1.  From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.

Authors:  Kanwal Pratap Singh Raghav; Sminil Mahajan; James C Yao; Brian P Hobbs; Donald A Berry; Rebecca D Pentz; Alda Tam; Waun K Hong; Lee M Ellis; James Abbruzzese; Michael J Overman
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

2.  Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications.

Authors:  Steven Woloshin; Lisa M Schwartz; Pamela J Bagley; Heather B Blunt; Brian White
Journal:  JAMA       Date:  2018-01-23       Impact factor: 56.272

3.  Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials.

Authors:  Fei Liang; Xinmei Guo; Sheng Zhang; Hongxi Xue; Qiang Chen; Xichun Hu
Journal:  Oncotarget       Date:  2017-10-03
  3 in total
  1 in total

1.  'The same old story': thoughts on authorized doses of anticancer drugs.

Authors:  Fausto Meriggi; Alberto Zaniboni
Journal:  Ther Adv Med Oncol       Date:  2020-02-22       Impact factor: 8.168
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.